Advertisement Berry Consultants acquires 100% interest in clinical trial simulation software - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Berry Consultants acquires 100% interest in clinical trial simulation software

Berry Consultants announced that it has reached an agreement with Tessella to acquire 100% ownership of FACTS (Fixed and Adaptive Clinical Trial Simulator).

Previously, FACTS was jointly developed and owned by Berry Consultants and Tessella, but this agreement gives Berry Consultants full ownership of the software.

FACTS allows biostatisticians and clinical teams to rapidly design and compare innovative, advanced, clinical trial designs. As part of the agreement, Tessella will remain as an IT service contractor of Berry Consultants providing support and transitional assistance as needed.

Berry Consultants president Dr Scott Berry noted FACTS is a powerful tool for the clinical trial industry today, but even more looking forward.

"We believe in the future all clinical trials will require the type of detailed, complex, simulations that FACTS provides — it is the flight simulator of a clinical trial. It allows trials to be run millions of times before the actual trial — to think through all the possibilities and outcomes before they occur. We appreciate Tessella’s partnership, support, and expertise in developing FACTS. It is the natural progression and growth of Berry Consultants to expand and develop FACTS going forward," Dr Berry added.